Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-12-13

Clinical Trial Update: Skin Immunity Sample Collection Involving Blisters and Biopsies [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial involving skin immunity sample collection for patients with Hyper-Immunoglobulin E Syndrome and Chronic Granulomatous Disease has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hyper-Immunoglobulin E. Syndrome (HEIS), Chronic Granulomatous Disease (CGD) | EARLY_Phase 1 | Status: WITHDRAWN